Cancer Prevention Pharmaceuticals Inc

$80$125

Cancer Prevention Pharmaceuticals, Inc. develops and markets therapeutic agents for the treatment and prevention of certain pre-cancerous conditions, orphan diseases, and gastrointestinal conditions. The company’s product, CPP-1X/sul, which is in Phase III clinical trials for the treatment of familial adenomatous polyposis and colon cancer risk reduction. The company also develops CPP-1X in Phase I and Phase II trials for the treatment of gastric cancer, neuroblastoma, and early-onset type 1 diabetes

Report ID:

UMHE21766

Published:

Jan-2022

Pages:

13

Industry:

HeadQuatered Country:

United States

Geography:

Clear
  Get a Free Sample
SKU: UMHE21766 Category:
Scope
Table of content
Companies Mentioned

Scope

“Overview of the company and its product offering
Detailed insight into its Strategy, Vision, Product Portfolio, and Business Headquarter
Information on its recent developments including partnerships, collaborations, and expansions among others
Biography of top management”

You can also purchase parts of this report. Do you want to check out a section wise
price list?

“1.    Key Facts of the Company
2.    Company Mission
3.    Company Value
4.    Growth Strategy
5.    Key Products & Services Offered
6.    Infographic
7.    Competitors
8. History/Timeline
9. Executive team
10.   SWOT Analysis
11. Products Portfolio
12.   Recent Development
12.1 Product Launches
12.2 Partnership
12.3 Business Expansions & Investments
12.4 Mergers and Acquisitions”

Companies Mentioned

“Biokine Therapeutics
PROTAGONIST THERAPEUTICS
Alios BioPharma
Leap Therapeutics
Visterra”